Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Coelho, A. S. Santos, R. Rosa, D. Maia, T. Sá, V. Caldeira, L. Semedo, J. Cardoso (Lisbon, Portugal). The importance of dyspnea and airflow limitation for anxiety and depression in COPD. Eur Respir J 2014; 44: Suppl. 58, 3002

Member's Comments

No comment yet.

Related content which might interest you: Symptoms for anxiety and depression in COPD patients Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Frequency of depression in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Exploring the association between psychological distress and dyspnea in COPD Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Factors influencing cognitive function in COPD Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Outpatients with asthma and irreversible airflow limitation - Some clinical characteristics Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Impact of airflow obstruction severity on the course of COPD during follow-up Source: International Congress 2014 – Lung function testing: new findings and new approaches Year: 2014 Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Assessing COPD profiles and outcomes by dyspnoea severity Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Determinants of severity of dyspnea in COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Collateral damage: Depressive symptoms in the spouses of COPD patients Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Sleep quality in patients with asthma and COPD Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Is anxiety and depression a barrier to enrolment in a study in chronic obstructive pulmonary disease (COPD)? Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Impact of pulmonary rehabilitation on cough and sputum symptom perception in patients with COPD Source: International Congress 2015 – Latest insights into pulmonary rehabilitation Year: 2015 COPD and depression: Prevalence and interaction Source: International Congress 2014 – Comorbidities Year: 2014